India

Maharashtra reports less than 5,000 new COVID-19 cases for 8 consecutive days

India confirms first Omicron-related death as Covid-19 cases jump

By Administrator_ India

Capital Sands

Maharashtra has reported less than 5,000 fresh coronavirus infections for eight days straight. With 4,259 new COVID-19 cases being reported on December 12, Maharashtra’s total infection tally stood at 18,76,699.

The active cases in the state currently stand at 73,542, which constitutes 3.91 percent of Maharashtra’s total coronavirus cases. The state’s total COVID-19 death toll at present is 48,139 with 80 new COVID-19 fatalities being reported on December 12. State health officials have informed, 50 of these were from the past 48 hours, 17 from the last week, and 13 deaths were from before last week.

In the first 12 days of October, 1,44,934 new coronavirus infections were reported. As against this, only 55,587 fresh COVID-19 cases were reported in the first 12 days of November, which further reduced to 55,053 fresh infections being reported in the corresponding period in December. As per Maharashtra Health Department data, the per day case average has come down to 4,587 this month, as against 4,632 in November and 12,077 in October.

Maharashtra has treated and discharged a total of 1,753,922 coronavirus patients so far and the recovery rate in the state is 93.46 percent. Mumbai continues to report the maximum number of fresh coronavirus cases with 680 new infections being reported on December 12. The city’s total COVID-19 case tally is 2,90,030 at present, including 12,520 active cases.

Administrator_India

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Indian bond yields surge as government borrowing balloons
India

Indian bond yields surge as government borrowing balloons

By Ritu, Capital Sands India’s benchmark 10-year bond yield surged on Monday following the government’s decision to sharply increase market
COVID19 India

India approves emergency use of remdesivir to treat COVID-19 patients

By Administrator_India Capital Sands India’s government said on Tuesday it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency